Department of Frontier Medicine, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan.
Int J Rheum Dis. 2009 Jul;12(2):90-9. doi: 10.1111/j.1756-185X.2009.01390.x.
Recently, attention has been attracted by the finding that overexpression of caveolin-1 induces cellular senescence in age-related diseases. We aimed to ascertain whether angiogenic growth factors (AGFs) can inhibit interleukin (IL)-1beta-induced senescence in human chondrocytes by downregulation of caveolin-1.
We investigated the intracellular signalling pathways involved in chondrocyte ageing. Human chondrocytes were isolated from the articular cartilage of patients undergoing arthroplastic knee surgery in osteoarthritis (OA). Chondrocytes were stimulated with or without IL-1beta (10 ng/mL) in the presence or absence of vascular endothelial growth factor, basic fibroblast growth factor or hepatocyte growth factor (20 ng/mL). After 72-h incubation, we observed the expression of caveolin-1 in human chondrocytes by immunohistochemistry, and analysed the protein levels of caveolin-1 by Western blot. We examined the time-course of phosphorylation patterns of mammalian mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3-K) by Western blot, and used several specific protein kinase inhibitors to evaluate the involvement of the intracellular signalling pathways. Also, chondrocyte replicative lifespan was analyzed in the presence or absence of AGFs.
Treatment with AGFs inhibited IL-1beta-induced overexpression of caveolin-1 in human OA chondrocytes. Treatment with AGFs all down-regulated protein levels of IL-1beta-accelerated expression of caveolin-1 in chondrocytes. IL-1beta significantly decreased the cellular replicative lifespan in chondrocytes. Treatment with AGFs prevented the IL-1beta-induced shortening of chondrocyte replicative lifespan. The specific inhibitors for MAPK/extracellular signal-regulated kinase and PI3-K cancelled the AGF-induced downregulation of overexpression of caveolin-1.
Our results suggest that AGFs downregulated IL-1beta-induced chondrocyte ageing and overexpression of caveolin-1 in human chondrocytes, which is mediated by kinase cascades involving the p42/44 MAP kinase and PI3-K/Akt signalling pathways.
最近,人们发现 caveolin-1 的过表达会诱导与年龄相关的疾病中的细胞衰老,这引起了人们的关注。我们旨在确定血管生成生长因子(AGFs)是否可以通过下调 caveolin-1 来抑制白细胞介素(IL)-1β诱导的人软骨细胞衰老。
我们研究了参与软骨细胞衰老的细胞内信号通路。从接受膝关节成形术的骨关节炎(OA)患者的关节软骨中分离出人软骨细胞。在存在或不存在血管内皮生长因子、碱性成纤维细胞生长因子或肝细胞生长因子(20ng/ml)的情况下,用或不用 IL-1β(10ng/ml)刺激软骨细胞。孵育 72 小时后,通过免疫组织化学观察人软骨细胞中 caveolin-1 的表达,并通过 Western blot 分析 caveolin-1 的蛋白水平。我们通过 Western blot 检测哺乳动物有丝分裂原激活蛋白激酶(MAPK)和磷脂酰肌醇 3-激酶(PI3-K)的磷酸化模式的时程,并使用几种特定的蛋白激酶抑制剂来评估细胞内信号通路的参与情况。此外,还在存在或不存在 AGFs 的情况下分析软骨细胞的复制寿命。
AGFs 的处理抑制了人 OA 软骨细胞中 IL-1β诱导的 caveolin-1 过表达。AGFs 的处理均下调了 IL-1β加速软骨细胞中 caveolin-1 表达的蛋白水平。IL-1β显著缩短了软骨细胞的细胞复制寿命。AGFs 的处理可防止 IL-1β诱导的软骨细胞复制寿命缩短。MAPK/细胞外信号调节激酶和 PI3-K 的特异性抑制剂取消了 AGF 诱导的 caveolin-1 过表达下调。
我们的结果表明,AGFs 下调了人软骨细胞中 IL-1β诱导的软骨细胞衰老和 caveolin-1 的过表达,这是通过涉及 p42/44 MAP 激酶和 PI3-K/Akt 信号通路的激酶级联介导的。